Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...

The Philadelphia HIV Resource Finder allows Philadelphians to search for treatment and prevention resources throughout the city.

Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure ...

A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...

Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.

Lenacapavir is administered twice a year and is designed to provide sustained protection against HIV infection.

By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic ...

Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...

Executive actions in 2025 produced a 90-day freeze and stop orders; waivers incompletely restored services, with notable gaps in PrEP access for nonpregnant, nonbreastfeeding individuals. New research ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.